Szasz MA - Search Results

1

Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer.

Bakacs T, Moss RW, Kleef R, Szasz MA, Anderson CC. Bakacs T, et al. Among authors: szasz ma. Scand J Immunol. 2019 Dec;90(6):e12821. doi: 10.1111/sji.12821. Epub 2019 Oct 7. Scand J Immunol. 2019. PMID: 31589347 Free article. Review.

2

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

Kleef R, Nagy R, Baierl A, Bacher V, Bojar H, McKee DL, Moss R, Thoennissen NH, Szász M, Bakacs T. Kleef R, et al. Cancer Immunol Immunother. 2021 May;70(5):1393-1403. doi: 10.1007/s00262-020-02751-0. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151369 Free PMC article.

3

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.

Mihály Z, Kormos M, Lánczky A, Dank M, Budczies J, Szász MA, Győrffy B. Mihály Z, et al. Among authors: szasz ma. Breast Cancer Res Treat. 2013 Jul;140(2):219-32. doi: 10.1007/s10549-013-2622-y. Epub 2013 Jul 9. Breast Cancer Res Treat. 2013. PMID: 23836010

4

The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer.

Teleki I, Krenacs T, Szasz MA, Kulka J, Wichmann B, Leo C, Papassotiropoulos B, Riemenschnitter C, Moch H, Varga Z. Teleki I, et al. Among authors: szasz ma. BMC Cancer. 2013 Feb 2;13:50. doi: 10.1186/1471-2407-13-50. BMC Cancer. 2013. PMID: 23374644 Free PMC article.

5

Gene expression-based prognostic and predictive tools in breast cancer.

Munkácsy G, Szász MA, Menyhárt O. Munkácsy G, et al. Among authors: szasz ma. Breast Cancer. 2015 May;22(3):245-52. doi: 10.1007/s12282-015-0594-y. Epub 2015 Feb 10. Breast Cancer. 2015. PMID: 25874688 Review.

6

[The adjuvant killing effect of modulated electro-hyperthermia combined with chemotherapy on B16F10 melanoma cells].

Major E, Benedek A, Szász MA, Benyó Z, Balogh A. Major E, et al. Among authors: szasz ma. Magy Onkol. 2021 Mar 17;65(1):71-77. Epub 2020 Feb 21. Magy Onkol. 2021. PMID: 33730119 Free article. Hungarian.

7

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.

Green AR, Soria D, Powe DG, Nolan CC, Aleskandarany M, Szász MA, Tőkés AM, Ball GR, Garibaldi JM, Rakha EA, Kulka J, Ellis IO. Green AR, et al. Among authors: szasz ma. Breast Cancer Res Treat. 2016 May;157(1):65-75. doi: 10.1007/s10549-016-3804-1. Epub 2016 Apr 26. Breast Cancer Res Treat. 2016. PMID: 27116185 Free PMC article.

8

[Morphological and immunophenotypical heterogeneity in breast cancers of young and elderly women].

Madaras L, Szász MA, Baranyák Z, Tõkés AM, Szittya L, Lotz G, Székely B, Szentmártoni G, Dank M, Baranyai Z, Kulka J. Madaras L, et al. Among authors: szasz ma. Magy Onkol. 2012 May;56(2):75-8. Epub 2012 Jan 17. Magy Onkol. 2012. PMID: 22629543 Free article. Hungarian.

9

Breast carcinoma subtypes show different patterns of metastatic behavior.

Molnár IA, Molnár BÁ, Vízkeleti L, Fekete K, Tamás J, Deák P, Szundi C, Székely B, Moldvay J, Vári-Kakas S, Szász MA, Ács B, Kulka J, Tőkés AM. Molnár IA, et al. Among authors: szasz ma. Virchows Arch. 2017 Mar;470(3):275-283. doi: 10.1007/s00428-017-2065-7. Epub 2017 Jan 19. Virchows Arch. 2017. PMID: 28101678

10

[Clinico-pathologically focused breast cancer research].

Kulka J, Tõkés AM, Madaras L, Kovács A, Ács B, Illyés I, Kiss O, Székely B, Lotz G, Szász MA. Kulka J, et al. Among authors: szasz ma. Magy Onkol. 2015 Dec;59(4):286-91. Epub 2015 Oct 12. Magy Onkol. 2015. PMID: 26665188 Free article. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page